
CBIO
Healthcare · Biotechnology · $591.3M market cap
$14.15-0.22 (-1.5%)Nov 13, 4:00 PM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · +1.6% over 90 days · 30-day revisions 1 up, 0 down
Beat estimates in 2 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 12, 2026 | After the close | -0.72 | -0.90 | -25.0% |
| Jul 30, 2026 | Before the open | -0.78 | -0.74 | +5.1% |
| Apr 30, 2026 | Time not confirmed | -0.79 | -0.70 | +11.0% |
| Feb 26, 2026 | Before the open | -2.22 | -4.01 | -80.6% |
| Nov 6, 2025 | Before the open | -1.38 | -1.37 | +0.7% |
| Jul 31, 2025 | Before the open | -3.68 | -3.72 | -1.1% |
| Jun 18, 2025 | After the close | -3.64 | -18.39 | -405.2% |
| Feb 27, 2025 | Time not confirmed | -0.09 | -0.08 | +11.1% |
| Nov 29, 2024 | Time not confirmed | -0.11 | -15.24 | -13750.3% |
| Aug 1, 2024 | Time not confirmed | -0.16 | -0.15 | +3.1% |
| May 10, 2024 | Time not confirmed | -0.17 | -0.17 | 0.0% |
| Mar 27, 2024 | Time not confirmed | -0.15 | -0.14 | +6.7% |
| Nov 3, 2023 | Time not confirmed | -0.14 |
Crescent Biopharma, Inc., a biotechnology company, researches and develops cancer therapy candidates in the United States. Its pipeline includes CR-001, which is in Phase 3 clinical trial, a proprietary anti-PD-1/anti-VEGF bispecific antibody to treat solid tumors; and CR-002, and CR-003. The company has a strategic partnership with Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. for the development and…
| -0.14 |
| 0.0% |
| Aug 2, 2023 | Time not confirmed | -0.18 | -0.13 | +27.8% |
| May 3, 2023 | Time not confirmed | -0.16 | -0.17 | -6.3% |
| Mar 29, 2023 | Time not confirmed | -0.17 | -0.19 | -11.8% |
| Nov 9, 2022 | Time not confirmed | -0.25 | -0.16 | +36.0% |
| Aug 3, 2022 | Time not confirmed | -0.25 | -0.25 | 0.0% |
| Apr 28, 2022 | Time not confirmed | -0.28 | -0.28 | 0.0% |
| Mar 3, 2022 | Time not confirmed | -0.33 | -0.33 | 0.0% |
| Nov 2, 2021 | Time not confirmed | -0.34 | -0.34 | 0.0% |
| Aug 5, 2021 | Time not confirmed | -0.28 | -0.28 | 0.0% |
| May 3, 2021 | Time not confirmed | -0.28 | -0.28 | 0.0% |
| Mar 2, 2021 | Time not confirmed | -0.32 | -0.32 | 0.0% |
| Nov 6, 2020 | Time not confirmed | -0.29 | -0.29 | 0.0% |
| Jul 31, 2020 | Time not confirmed | -0.32 | -0.32 | 0.0% |
| May 1, 2020 | Time not confirmed | -0.18 | -0.18 | 0.0% |
| Feb 28, 2020 | Time not confirmed | -0.34 | -0.34 | 0.0% |
| Nov 7, 2019 | Time not confirmed | -0.31 | -0.31 | 0.0% |
| Aug 1, 2019 | Time not confirmed | -0.37 | -0.37 | 0.0% |
| May 2, 2019 | Time not confirmed | -0.34 | -0.33 | +2.9% |
| Mar 6, 2019 | Time not confirmed | -0.30 | -0.32 | -6.7% |
| Nov 2, 2018 | Time not confirmed | -0.30 | -0.27 | +10.0% |
| Aug 9, 2018 | Time not confirmed | -0.33 | -0.26 | +21.2% |
| May 3, 2018 | Time not confirmed | -0.28 | -0.33 | -17.9% |
| Mar 6, 2018 | Time not confirmed | -0.26 | -0.27 | -3.8% |